Hedgehog lipids: Promotors of alternative morphogen release and signaling?

Abstract

Two posttranslational lipid modifications present on all Hedgehog (Hh) morphogensan N-terminal palmitate and a C-terminal cholesterol-are established and essential regulators of Hh biofunction. Yet, for several decades, the question of exactly how both lipids contribute to Hh signaling remained obscure. Recently, cryogenic electron microscopy revealed different modes by which one or both lipids may contribute directly to Hh binding and signaling to its receptor Patched1 (Ptc). Some of these modes demand that the established release factor Dispatched1 (Disp) extracts dual-lipidated Hh from the cell surface, and that another known upstream signaling modulator called Scube2 chaperones the dual-lipidated morphogen to Ptc. By mechanistically and biochemically aligning this concept with established in vivo and recent in vitro findings, this reflection identifies remaining questions in lipidated Hh transport and evaluates additional mechanisms of Disp-and Scube2-regulated release of a second bioactive Hh fraction that has one or both lipids removed.

Hedgehog signalling in bone and osteoarthritis: the role of Smoothened and cholesterol

“…HH ligand, its receptor PTCH1 and the GPCR SMO are all components of the HH pathway that can be lipidated. Manikowski et al (2021) [72] proposed the theory that the ability to release dually lipidated, monolipidated or delipidated HH ligands may be cell or tissuespecific and contribute to the finely tuned morphogenic potential of HH signalling. In this review, however, we will focus on the cholesterylation of SMO and its role as a gatekeeper to downstream HH signalling.…”